Kevin Strange's most recent trade in Inari Medical Inc was a trade of 21,102 Common Stock done . Disclosure was reported to the exchange on Feb. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inari Medical Inc | Kevin Strange | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 21,102 | 67,502 | - | 0 | Common Stock | |
| Inari Medical Inc | Kevin Strange | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.05 per share. | 01 Jan 2025 | 276 | 46,464 | - | 51.1 | 14,090 | Common Stock |
| Inari Medical Inc | Kevin Strange | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.05 per share. | 01 Jan 2025 | 227 | 46,740 | - | 51.0 | 11,588 | Common Stock |
| Inari Medical Inc | Kevin Strange | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.05 per share. | 01 Jan 2025 | 176 | 46,967 | - | 51.1 | 8,985 | Common Stock |
| Inari Medical Inc | Kevin Strange | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.05 per share. | 01 Jan 2025 | 149 | 47,143 | - | 51.0 | 7,606 | Common Stock |
| Inari Medical Inc | Kevin Strange | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.05 per share. | 01 Jan 2025 | 146 | 46,318 | - | 51.0 | 7,453 | Common Stock |
| Inari Medical Inc | Kevin Strange | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.05 per share. | 01 Jan 2025 | 63 | 47,292 | - | 51.0 | 3,216 | Common Stock |
| Inari Medical Inc | Kevin Strange | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 5,695 | 48,396 | - | 0 | Common Stock | |
| Inari Medical Inc | Kevin Strange | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.63 per share. | 01 Oct 2024 | 268 | 48,128 | - | 40.6 | 10,889 | Common Stock |
| Inari Medical Inc | Kevin Strange | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.63 per share. | 01 Oct 2024 | 240 | 47,355 | - | 40.6 | 9,751 | Common Stock |
| Inari Medical Inc | Kevin Strange | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.63 per share. | 01 Oct 2024 | 198 | 47,595 | - | 40.6 | 8,045 | Common Stock |
| Inari Medical Inc | Kevin Strange | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.63 per share. | 01 Oct 2024 | 152 | 47,793 | - | 40.6 | 6,176 | Common Stock |
| Inari Medical Inc | Kevin Strange | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.63 per share. | 01 Oct 2024 | 129 | 47,945 | - | 40.6 | 5,241 | Common Stock |
| Inari Medical Inc | Kevin Strange | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.63 per share. | 01 Oct 2024 | 54 | 48,074 | - | 40.6 | 2,194 | Common Stock |